234
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis

& ORCID Icon
Pages 305-312 | Received 06 Jun 2023, Accepted 21 Sep 2023, Published online: 18 Oct 2023